Olaparib

CAS 763113-22-0 20 current recordsSmall Molecule

Who holds supplier records for Olaparib? 20 organisations hold a current record for Olaparib: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (11), China (4), Taiwan (1) and Italy (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Olaparib: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/olaparib

Reading the evidence

  • 20 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    11 of the 17 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 13 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Olaparib expires 25 Oct 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (20)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Olaparib. Country is the organisation's recorded country, not necessarily the manufacturing site.

India11China4Taiwan1Italy1Country not recorded for 3
  • BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED
    Active DMF 40467, 43716 · latest filing Mar 2026
    India
  • Hetero Labs Limited
    Active DMF 35831, 43374 · latest filing Apr 2026
    India Company GMP cert on record
  • HUADONG MEDICINE (XI'AN) BODYGUARD PHARMACEUTICAL CO LTD
    Active DMF 40462, 42596 · latest filing Nov 2025
  • MSN Laboratories Private Limited
    Active DMF 43952, 34698 · latest filing Mar 2026
    India Company GMP cert on record
  • SCINOPHARM TAIWAN LTD
    Active DMF 32629, 42340 · latest filing Sept 2025
    Taiwan
  • Alembic Pharmaceuticals Limited
    Active DMF 32505 · latest filing Mar 2018
    India Company GMP cert on record
  • ALIVUS LIFE SCIENCES LTD
    Active DMF 38957 · latest filing Sept 2023
    India Company GMP cert on record
  • ALP PHARM BEIJING CO LTD
    Active DMF 31219 · latest filing Dec 2016
  • BDR LIFESCIENCES PRIVATE LIMITED
    Active DMF 42527 · latest filing Sept 2025
    India Company GMP cert on record
  • Biocon Limited
    Active DMF 41344 · latest filing Mar 2025
    India
  • CAMBREX PROFARMACO MILANO SRL
    Active DMF 39524 · latest filing Feb 2024
    Italy Company GMP cert on record
  • CDYMAX (INDIA) PHARMA PRIVATE LIMITED
    Active DMF 42143 · latest filing Jun 2025
    India Company GMP cert on record
  • Cipla Limited
    Active DMF 37240 · latest filing Aug 2022
    India Company GMP cert on record
  • Deva Holding As
    Active DMF 43529 · latest filing Feb 2026
    Company GMP cert on record
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 35742 · latest filing Mar 2021
    India Company GMP cert on record
  • Intas Pharmaceuticals Ltd.
    Active DMF 42359 · latest filing Sept 2025
    India Company GMP cert on record
  • Shandong Anhong Pharmaceutical Co., Ltd.
    Active DMF 38395 · latest filing Jun 2023
    China Company GMP cert on record
  • Sichuan Kelun Pharmaceutical Co., Ltd.
    Active DMF 40679 · latest filing Oct 2024
    China
  • Wisdom Pharmaceutical Co., Ltd
    Active DMF 38136 · latest filing Mar 2023
    China
  • Zhejiang Ausun Pharmaceutical Co., Ltd.
    Active DMF 41845 · latest filing Apr 2025
    China Company GMP cert on record
Need Olaparib sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (2 listed products contain Olaparib). The latest listed patent expires 25 Oct 2041. The latest listed exclusivity runs to 8 May 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Olaparib is a potent oral PARP inhibitor with anti-tumor activity, specifically designed to exploit the DNA-repair pathway deficiencies in cancer cells. It is primarily used for the treatment of ovarian, breast, and certain other types of cancer linked to BRCA mutations.

Chemical identity

IUPAC name
4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one
Canonical SMILES
C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F
InChIKey
FDLYAMZZIXQODN-UHFFFAOYSA-N
Synonyms
Lynparza API, az-2281, az2281, azd-2281, azd2281, keylynk-010 component olaparib, ku-0059436, ku-59436, lynparza, nsc-747856

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Poly(ADP-Ribose) Polymerase Inhibitor
Mechanism of action
Poly(ADP-Ribose) Polymerase Inhibitors

Therapeutic areas

OncologyCancer Treatment

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Olaparib?

20 organisations hold an active US FDA Type II Drug Master File or a CEP for Olaparib: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Hetero Labs Limited (India), HUADONG MEDICINE (XI'AN) BODYGUARD PHARMACEUTICAL CO LTD, MSN Laboratories Private Limited (India), SCINOPHARM TAIWAN LTD (Taiwan), Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India) and ALP PHARM BEIJING CO LTD, and 12 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Olaparib Drug Master Files are active?

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 40467, 43716), Hetero Labs Limited (DMF 35831, 43374), HUADONG MEDICINE (XI'AN) BODYGUARD PHARMACEUTICAL CO LTD (DMF 40462, 42596), MSN Laboratories Private Limited (DMF 43952, 34698), SCINOPHARM TAIWAN LTD (DMF 32629, 42340), Alembic Pharmaceuticals Limited (DMF 32505), ALIVUS LIFE SCIENCES LTD (DMF 38957) and ALP PHARM BEIJING CO LTD (DMF 31219) and 12 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does the FDA Orange Book list patents for products containing Olaparib?

Yes. The latest patent listed for an approved US product containing Olaparib expires 25 Oct 2041, across 2 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Olaparib supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Olaparib?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.